Perigon Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $920K | Buy |
37,795
+4,471
| +13% | +$109K | 0.02% | 493 |
|
2025
Q1 | $692K | Sell |
33,324
-4,712
| -12% | -$97.8K | 0.02% | 536 |
|
2024
Q4 | $922K | Sell |
38,036
-8,305
| -18% | -$201K | 0.02% | 464 |
|
2024
Q3 | $1.19M | Sell |
46,341
-3,903
| -8% | -$99.9K | 0.03% | 387 |
|
2024
Q2 | $1.18M | Buy |
50,244
+13,716
| +38% | +$322K | 0.03% | 336 |
|
2024
Q1 | $1.05M | Buy |
36,528
+6,945
| +23% | +$200K | 0.03% | 359 |
|
2023
Q4 | $971K | Buy |
29,583
+3,380
| +13% | +$111K | 0.03% | 344 |
|
2023
Q3 | $730K | Buy |
26,203
+6,864
| +35% | +$191K | 0.03% | 367 |
|
2023
Q2 | $659K | Buy |
19,339
+3,803
| +24% | +$130K | 0.03% | 390 |
|
2023
Q1 | $467K | Buy |
15,536
+1,608
| +12% | +$48.4K | 0.03% | 409 |
|
2022
Q4 | $393K | Sell |
13,928
-2,806
| -17% | -$79.2K | 0.02% | 448 |
|
2022
Q3 | $550K | Sell |
16,734
-210
| -1% | -$6.9K | 0.05% | 313 |
|
2022
Q2 | $534K | Buy |
16,944
+5,736
| +51% | +$181K | 0.04% | 319 |
|
2022
Q1 | $515K | Sell |
11,208
-249
| -2% | -$11.4K | 0.04% | 352 |
|
2021
Q4 | $702K | Sell |
11,457
-1,001
| -8% | -$61.3K | 0.05% | 273 |
|
2021
Q3 | $931K | Buy |
12,458
+779
| +7% | +$58.2K | 0.08% | 211 |
|
2021
Q2 | $1.08M | Buy |
11,679
+972
| +9% | +$89.9K | 0.1% | 184 |
|
2021
Q1 | $950K | Sell |
10,707
-73
| -0.7% | -$6.48K | 0.1% | 188 |
|
2020
Q4 | $1.01M | Buy |
10,780
+2,404
| +29% | +$224K | 0.12% | 144 |
|
2020
Q3 | $534K | Buy |
8,376
+811
| +11% | +$51.7K | 0.07% | 209 |
|
2020
Q2 | $395K | Buy |
7,565
+981
| +15% | +$51.2K | 0.06% | 221 |
|
2020
Q1 | $219K | Buy |
+6,584
| New | +$219K | 0.04% | 286 |
|
2018
Q2 | – | Sell |
-2,770
| Closed | -$71K | – | 256 |
|
2018
Q1 | $71K | Hold |
2,770
| – | – | 0.03% | 274 |
|
2017
Q4 | $68K | Buy |
+2,770
| New | +$68K | 0.03% | 252 |
|